2 drug(s) with this reaction
1,596 total reports
Dry Skin has been reported as an adverse reaction across 2 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,596 adverse event reports mention dry skin in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with dry skin, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have dry skin listed in their FDA adverse event reports, sorted by report count:
In addition to dry skin, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
2 drug(s) manufactured by Amgen Inc have dry skin listed in their FDA adverse event reports: DENOSUMAB, PANITUMUMAB.
There are a combined 1,596 reports of dry skin across 2 Amgen Inc drug(s) in the FDA adverse event database.